ERALP, Y. Et Al. 2013. Predictive Role of Midtreatment Changes in Survivin, GSTP1 and Topoisomerase 2a Expressions for Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer. AMERICAN JOURNAL OF CLINICAL CLINICAL ONCOLOGY , vol.36, no.3 , 215-223.

ERALP, Y., KESKİN, S., YÖRÜKER, E. E., AKIŞIK, E., İĞCİ, A., MÜSLÜMANOĞLU, M. E., ... Yılmaz, S.(2013). Predictive Role of Midtreatment Changes in Survivin, GSTP1 and Topoisomerase 2a Expressions for Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer. AMERICAN JOURNAL OF CLINICAL CLINICAL ONCOLOGY , vol.36, no.3, 215-223.

ERALP, Yeşim Et Al. "Predictive Role of Midtreatment Changes in Survivin, GSTP1 and Topoisomerase 2a Expressions for Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer," AMERICAN JOURNAL OF CLINICAL CLINICAL ONCOLOGY , vol.36, no.3, 215-223, 2013

ERALP, Yeşim Et Al. "Predictive Role of Midtreatment Changes in Survivin, GSTP1 and Topoisomerase 2a Expressions for Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer." AMERICAN JOURNAL OF CLINICAL CLINICAL ONCOLOGY , vol.36, no.3, pp.215-223, 2013

ERALP, Y. Et Al. (2013) . "Predictive Role of Midtreatment Changes in Survivin, GSTP1 and Topoisomerase 2a Expressions for Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer." AMERICAN JOURNAL OF CLINICAL CLINICAL ONCOLOGY , vol.36, no.3, pp.215-223.

@article{article, author={Yeşim ERALP Et Al. }, title={Predictive Role of Midtreatment Changes in Survivin, GSTP1 and Topoisomerase 2a Expressions for Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer}, journal={AMERICAN JOURNAL OF CLINICAL CLINICAL ONCOLOGY}, year=2013, pages={215-223} }